What OZ Biosciences does

OZ Biosciences is a France-based biotechnology company founded in 2002 that designs, develops, and manufactures molecular delivery systems used by academic, pharmaceutical, and biotechnology researchers worldwide. The firm specializes in transfection and transduction tools spanning four proprietary technology platforms: Magnetofection (magnetic-field-driven delivery), Lipofection (lipid-based reagents such as the DreamFect family), Polyfection (polymer-based delivery), and I-MICST (integrated magnetic immuno-cell sorting and transfection). Its catalog of 140+ reagents includes DNA, siRNA, mRNA, and CRISPR delivery kits; viral transduction enhancers (LentiBlast Premium, ViroMag, AAVBlast); the NanOZ Lipid Nanoparticle (LNP) platform built on clinically validated SM-102 and MC3 ionizable lipids for organ-selective in vivo delivery; the ExploCap co-transcriptional mRNA/saRNA capping technology; vaccine adjuvants; and cellular assay kits. Custom mRNA synthesis, custom saRNA synthesis, and custom LNP formulation services complement the catalog for research and translational customers.

The company monetizes through direct e-commerce sales from ozbiosciences.com and a hybrid distribution model with 35+ global partners, including ThermoFisher Scientific, VWR (Avantor), Dutscher Group, Funakoshi, and CliniSciences. Pricing is unit-based with significant tier differentiation between research-use-only SKUs ($50-$500 per reaction typical), process-development grades, and the recently launched LentiBlast Premium Superior Grade clinical/CGT-grade SKU ($751-$1,945) carrying USP <63> and USP <85> QC testing. Two primary legal entities, OZ Biosciences SAS in Marseille and OZ Biosciences USA Inc. in San Diego, handle direct sales for EMEA and North America respectively, with stated strategic-alliance pursuits targeting pharma, biotech, and CDMOs for long-term multi-project collaborations. The customer base is horizontally diversified across academic and research institutions and pharmaceutical/biotechnology companies, with secondary use-case segments in 3D biology/organoids, neuroscience, vaccine research, and bioproduction. Independent and privately held, with no disclosed external venture or private equity financing beyond early-stage support from Incubateur Impulse in 2003 and leadership under founder-CEO Olivier Zelphati, the company holds ISO 9001:2015 and French CIR Agreement certifications and reports 2,500+ peer-reviewed publications citing its products.

Name

OZ Biosciences

Legal name

OZ Biosciences

Website

https://ozbiosciences.com

Company type

Private

Founded year

2002

Operating status

Operating

Headcount range

11–50 employees

Short description

OZ Biosciences, founded in 2002 in Marseille, France, designs and manufactures proprietary molecular delivery systems for transfection, transduction, mRNA/LNP delivery, and viral production, supplying academic researchers, pharmaceutical companies, biotech firms, and CDMOs across 35+ countries via direct e-commerce and a global distributor network.

Ownership category

akta.pro rank

Product category

Life Sciences Reagents (Molecular Delivery / Transfection and Transduction)

NAICS

Research and Development in Biotechnology (except Nanobiotechnology) (541714), Biological Product (except Diagnostic) Manufacturing (325414)

SIC

Biological Products, (No Disgnostic Substances) (2836)

akta.pro primary industry

RNA Delivery Technologies (LNPs, polymers, conjugates incl. GalNAc, peptides, exosomes) (HLAAADAD)

akta.pro secondary industries

Non-viral Gene Delivery & Gene Therapy (LNP, polymers, electroporation, physical methods) (HLAAACAC), RNA Manufacturing & CMC (oligo synthesis, IVT, purification, formulation, QC) (HLAAADAF), RNA Therapeutics Platforms & Design (sequence design, target ID/validation, AI/bioinformatics) (HLAAADAG), RNA Chemistry & Oligonucleotide Engineering (backbones, modifications, stereochemistry) (HLAAADAE)

Keywords

• Transfection reagents
• Molecular delivery systems
• Lipid nanoparticles
• Viral transduction enhancers
• MRNA synthesis services

Headquarters

HQ city

Marseille

HQ country

France

HQ region

Europe

Offices2 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Personnel, Technology or R&D, Supply Chain, Operations, Marketing or Sales, Infrastructure

Revenue model

1. Transfection and Transduction Reagents: Sale of reagents for DNA, siRNA, mRNA, and CRISPR transfection including Magnetofection products, lipofection reagents, and polyfection reagents. One-time product purchases with various sizes available (100 µL to multi-mL kits).
2. Viral Applications Products: Products for virus production, preservation, capture, concentration, and transduction enhancement including LentiBlast, ViroMag, AdenoMag, and AAVBlast. One-time reagent purchases.
3. LNP Products: Lipid Nanoparticle products for mRNA and siRNA delivery including NanOZ LNP kits, fluorescent LNPs, empty LNPs, and DIY formulations. Includes clinically validated SM-102 and MC3 formulations.
4. mRNA and saRNA Products: Cap1 mRNAs and saRNAs for various applications including reporter genes, fluorescent proteins, genome editing, vaccines, gene replacement, cytokines, and transcription factors. Also includes IVT kits, capping kits, and poly(A) kits.
5. Custom Synthesis Services: Custom mRNA synthesis, custom saRNA synthesis, and custom LNP formulation services. Quote-based pricing for specialized research and development needs.
6. Vaccine Adjuvants: Adjuvant products for protein-based and mRNA/DNA-based vaccines including aluminum gels, DOTAP cationic liposomes, squalene emulsions, Freund's adjuvant, and surface reactive liposomes.
7. Cellular Assay Kits and Transfection Tools: Assay kits for beta-galactosidase, protein dosage, viability, cytotoxicity, alkaline phosphatase, stem cell senescence, and luciferase expression. Also includes antibiotics, luciferin, X-Gal substrate, and transfection controls.

Pricing tiers

Go-to-market motion3 records

Distribution channels4 records

Marketing channels7 records

Core offering

OZ Biosciences designs, develops and produces proprietary molecular delivery systems and reagents — lipid-, polymer- and magnetic-nanoparticle-based transfection and transduction tools — that enable laboratories to deliver DNA, siRNA, mRNA, CRISPR, proteins, antibodies and viral vectors into cells. Its catalog spans DNA/siRNA/mRNA transfection reagents (DreamFect, Lullaby), viral transduction enhancers (LentiBlast Premium, ViroMag, AAVBlast, HYVIR), a NanOZ Lipid Nanoparticle (LNP) platform for in vivo mRNA/siRNA delivery, Cap1 mRNAs and self-amplifying RNAs with the proprietary ExploCap capping technology, vaccine adjuvants, and cellular assay kits, supplemented by quote-based custom mRNA, saRNA and LNP formulation services for research and preclinical applications.

Product overview

OZ Biosciences is a biotechnology company that creates, develops, and produces innovative molecular delivery systems specialized in transfection and transduction tools for the worldwide scientific community and pharmaceutical industry. The product portfolio centers around core delivery technologies including Magnetofection (magnetic-based transfection), Lipofection (lipid-based transfection), and Polyfection (polymer-based transfection) platforms. Key product lines include: DNA/siRNA/mRNA transfection reagents (DreamFect, Lullaby families); viral transduction enhancers (LentiBlast Premium, ViroMag, AAVBlast) for lentivirus, adenovirus, and AAV delivery; NanOZ LNP (Lipid Nanoparticle) products for in vivo mRNA and siRNA delivery; mRNA products including Cap1 mRNAs, self-amplifying RNAs (saRNAs), and the proprietary ExploCap capping technology; vaccine adjuvants; cellular assay kits; and custom synthesis services for mRNA, saRNA, and LNP formulation. The company also offers specialized reagents for neuroscience applications (NeuroMag, Glial-Mag), protein delivery, bioproduction, and cell & gene therapy workflows. With over 22 years of expertise, 140+ life sciences reagents developed, and 2500+ publications citing their products, OZ Biosciences serves both research and clinical applications.

Differentiator

Problem solved

Functional benefit

Brands

• Magnetofection: Magnetic-based transfection technology platform using magnetic nanoparticles for enhanced molecular delivery
• NanOZ-LNP
• ExploCap
• LentiBlast
• HYVIR
• DreamFect
• NeuroMag

Products and services

• DNA Transfection Reagents (DreamFect Family) Lipid-based transfection reagents for DNA delivery into cells, including DreamFect for standard cell lines, DreamFect Gold as a gold-standard formulation, and DreamFect Stem for stem cell-specific applications; for researchers performing DNA transfection in cell lines, primary cells, stem cells, 3D cultures and explants.
• siRNA Transfection Reagents (Lullaby Family) Reagents for efficient siRNA delivery into cells for gene silencing applications, including variants for cell lines, primary cells, stem cells, 3D transfection and explants.
• mRNA / Viral RNA Transfection Reagents Transfection reagents optimized for mRNA and viral RNA delivery into cell lines and stem cells.
• CRISPR Cas9 Products Transfection reagents and tools specifically designed for CRISPR Cas9 genome editing workflows.
• LentiBlast Premium Patented chemical transduction enhancer that dramatically increases lentiviral infection and transduction efficiency across adherent and suspension cells, primary cells and cell lines; neutralizes electrostatic repulsion between membranes and viral particles and enhances viral fusion with the cell membrane in a non-toxic formulation.
• LentiBlast Premium Superior Grade Identical formulation to LentiBlast Premium with advanced quality controls — sterility, NMR chemical characterization, SEC purity, mycoplasma testing per USP <63> and endotoxin testing per USP <85> — designed as an ancillary material for preclinical and early-phase clinical trials in cell and gene therapy, including CAR-T workflows.
• ViroMag Magnetic nanoparticle formulation based on Magnetofection technology for increasing virus infection and transduction capacities across virus types, dramatically improving transduction with extremely low vector doses; requires a magnetic plate.
• NeuroMag Magnetic transfection reagent specifically designed for neurons, enabling efficient transfection of neurons from 1 DIV to 20 DIV.
• Glial-Mag Magnetic transfection reagent for microglial cell lines and primary glial cells.
• AAVBlast Non-toxic AAV transduction enhancer effective across a wide range of cell types and compatible with various AAV serotypes.
• HYVIR Transfection Reagent Lipid-based transfection kit dedicated to enhancing viral particle production in HEK-293T cells, optimized for co-transfection of four plasmids simultaneously in third-generation lentiviral production systems, completely animal origin free, and scalable across 1.5 mL to 30 mL kit sizes.
• NanOZ LNP-mRNA Ready-to-use lipid nanoparticle formulations with organ-selective biodistribution for in vivo mRNA delivery, validated for liver, spleen, multi-organ targeting and immunization applications, using clinically validated SM-102 and MC3 ionizable lipids.
• NanOZ LNP-siRNA Lipid nanoparticle formulations for siRNA delivery with precision gene silencing capabilities, including dual-labeled options with GFP, GAPDH and Cy5 for real-time tracking.
• NanOZ LNP-DIY Customizable LNP lipid mix allowing researchers to formulate their own lipid nanoparticles for specific applications.
• NanOZ Empty-LNP Empty lipid nanoparticles intended for control experiments and LNP formulation development.
• NanOZ Fluorescent-LNP Fluorescently labeled LNPs — DiI, DiO and DiR variants — for biodistribution tracking and cellular uptake studies.
• LNP Selection Kit Kit for screening and selecting optimal LNP formulations for specific delivery applications.
• ExploCap mRNA mRNA products using ExploCap, OZ Biosciences' next-generation cap analog technology for co-transcriptional capping with lower degradation risk and improved downstream manufacturability.
• ExploCap saRNA Self-amplifying RNA products using ExploCap capping technology for enhanced RNA stability and expression.
• Cap1 mRNAs Enzymatically capped Cap1 mRNA products spanning reporter genes, fluorescent proteins, genome editing tools, vaccine antigens, gene replacement sequences, cytokines/interleukins and transcription factors.
• Vaccine Adjuvants Adjuvant systems for protein-based and mRNA/DNA-based vaccines, including aluminum gels, DOTAP cationic liposomes, squalene emulsions, Freund's adjuvant and surface reactive liposomes.
• Cellular Assay Kits Assay kits including Beta-Gal, protein dosage, viability/stress/cytotoxicity, alkaline phosphatase, stem cell senescence and luciferase expression kits, for use alongside transfection and transduction experiments.
• Transfection Booster (CombiMag) Magnetic and non-magnetic transfection booster reagents to enhance transfection efficiency as add-ons to standard transfection protocols.
• Custom mRNA Synthesis Service Quote-based custom mRNA synthesis service with options for various capping technologies, modifications and specific sequences, including Cap1 structure and poly(A) tail, for reporter genes, fluorescent proteins, genome editing, vaccines, gene replacement and cytokines.
• Custom LNP Formulation Service Quote-based custom lipid nanoparticle formulation service for developing tailored LNP delivery systems for specialized research and development requirements.
• Custom saRNA Synthesis Service Quote-based custom self-amplifying RNA synthesis service for vaccine and therapeutic development applications, leveraging saRNA's replication capability over conventional mRNA.

Quantifiable outcome

• LentiBlast Premium allows achieving same transduction results with lower viral titer while maximizing cell viability with non-toxic formulation
• +2 more outcomes

Segments6 records

Ideal customer profiles4 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature11 records

Partnerships

Nine partnerships are on record, tiered major, regional, core and minor.

• ThermoFisher ScientificmajorChannel Partner/ Reseller/ DistributorThermoFisher Scientific is one of OZ Biosciences' distributors, providing global reach and access to ThermoFisher's extensive customer base in the life sciences research market.
• VWR (Avantor)majorChannel Partner/ Reseller/ DistributorVWR (now part of Avantor) distributes OZ Biosciences products, providing laboratory supplies distribution and local support to researchers worldwide.
• Dominique Dutscher / Milian SA Dutscher GroupmajorChannel Partner/ Reseller/ DistributorFrench and European distributor network under the Dutscher Group umbrella, providing local coverage in France and neighboring markets.
• FunakoshiregionalChannel Partner/ Reseller/ DistributorJapanese distributor for OZ Biosciences products, providing local sales and support for the Japanese research market.
• CliniSciencesregionalChannel Partner/ Reseller/ DistributorEuropean distributor specializing in research reagents and laboratory supplies, distributing OZ Biosciences products in their market coverage area.
• Additional Global DistributorsregionalChannel Partner/ Reseller/ Distributor30+ additional regional distributors including BOCA SCIENTIFIC Inc, Aurogene, AmyJet, Gaia, Joagene, BIO-CONNECT, BIOZOL, CALTAG, NORDIC DIAGNOSTICA, abyntek, Australian Biosearch, Tivan Biotech LTD, Biogenuix, SLS, LabLife Nordic AB, Lucerna-Chem AG, Thomas Scientific, Hölzel Diagnostika, ABBIOTEC, Biotechno Labs, MEDianus Pharma S.A., MOLGEN BIYOTEKNOLOJI, FERMELO Biotec, QUARTZY, Sputnik, and Biogenuix covering markets across Asia, Europe, Americas, Africa, and Oceania.
• Pharma and Biotech Companies (Strategic Alliances)coreStrategic or Co-development PartnerLong-term, multi-project collaborations with pharmaceutical and biotech companies or CDMOs. Can include joint investment, preferred supplier agreements, or first-rights of negotiation. Designed to build enduring partnerships for molecular delivery solutions.
• CDMOs (Contract Development and Manufacturing Organizations)coreStrategic or Co-development PartnerStrategic alliances with CDMOs for cell and gene therapy development, viral vector manufacturing, and vaccine production using OZ Biosciences delivery technologies.
• Academic InstitutionsminorStrategic or Co-development PartnerCollaborations with academic institutions for research tool development and translational applications. Includes participation in EU and internationally funded research projects through grants programs.

Scale indicators9 records

Recent moves6 records

Expansion highlights6 records

Direct peers

• Precision Nanosystems (Cytiva): Provides LNP formulation technology (NanoAssemblr platform) for mRNA therapeutics and gene therapy development. Direct peer in LNP-based mRNA/siRNA delivery with comparable custom formulation services.
• MaxCyte: Specializes in electroporation-based transfection (Flow Electroporation) for cell therapy manufacturing and gene editing. Comparable in targeting hard-to-transfect cells and clinical-grade delivery, with overlapping customer base in cell & gene therapy.
• Mirus Bio (Roche): Specializes in transfection reagents for DNA, siRNA, mRNA, and CRISPR delivery, with the TransIT family of products. Direct competitor across virtually every transfection category OZ Biosciences addresses, now with Roche's scale and resources.
• Polyplus (Sartorius): Develops transfection reagents (jetOPTIMUS, INTERFERin) and PEI-based delivery for gene therapy and vaccine manufacturing. Direct competitor in LNP and polymer-based delivery, particularly for bioproduction and viral vector applications.

Regional players

• Aldevron: Manufactures plasmids, mRNA, and proteins for gene therapy and vaccine developers. Adjacent peer in the gene therapy supply chain, particularly through nucleic acid production services that complement delivery reagent offerings.

Broad incumbents

• CordenPharma: CDMOs offering lipid excipients and LNP formulation services for mRNA therapeutics. Peer in the clinical-grade delivery and manufacturing services category where OZ Biosciences is positioning.
• Bio-Rad Laboratories: Offers Gene Pulser electroporation systems and transfection reagents for research and bioproduction. Broad incumbent in molecular delivery with comparable presence across academic and commercial customer segments.
• Evonik: Provides LNP formulation services and custom lipid manufacturing for mRNA therapeutics through its Health Care business. Increasingly significant competitor in the clinical-grade LNP space.
• Thermo Fisher Scientific: Global life sciences leader offering Lipofectamine transfection reagents and broad cell biology products. Both a major distributor of OZ Biosciences products and a competitor with its own delivery reagent portfolio.

Emerging players

• Vector Builder: Provides custom viral vector production and plasmid services with growing reagent offerings. Emerging peer with comparable service model for lentiviral, AAV, and CRISPR delivery applications.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat5 records

Key risks6 records

Key highlights6 records

Customer concentration

• Xx.com/OZBIOSCIENCES
• Facebookfacebook.com/transfectionmagnetofection
• LinkedInlinkedin.com/company/oz-biosciences

Compliance2 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds1 record

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about OZ Biosciences